Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 65Myelodysplastic Syndromes 64Leukemia, Myeloid, Acute 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 43Lymphoma 41Leukemia, Lymphocytic, Chronic, B-Cell 40Multiple Myeloma 35Hodgkin Disease 35Lymphoma, Non-Hodgkin 34Leukemia, Myeloid, Chronic-Phase 34Myeloproliferative Disorders 33Leukemia, Myeloid, Accelerated Phase 31Lymphoma, Follicular 28Lymphoma, B-Cell, Marginal Zone 28Congenital Abnormalities 28Burkitt Lymphoma 28Lymphoma, Mantle-Cell 27Lymphoma, Large B-Cell, Diffuse 27Neoplasms, Plasma Cell 23Lymphoma, Large-Cell, Immunoblastic 23Anemia, Refractory, with Excess of Blasts 23Blast Crisis 22Myelodysplastic-Myeloproliferative Diseases 19Leukemia, Myelomonocytic, Chronic 19Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19Graft vs Host Disease 19Dendritic Cell Sarcoma, Interdigitating 19Primary Myelofibrosis 17Waldenstrom Macroglobulinemia 14Recurrence 14

Interventions

Tacrolimus 1Phlebotomy 1Cyclosporins 1Cyclosporine 1Blood Specimen Collection 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Thymic aplasia × Antilymphocyte Serum × Clear all
NCT02274662 2025-01-16

Expanded Access Protocol Thymus Transplantation

Sumitomo Pharma Switzerland GmbH

Phase 4 Completed
11 enrolled 10 charts

Thymic aplasia, Immunologic Deficiency Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡